Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H LEVY

Showing results (871-880 of 925) with videos related to

Pageof 93
Sort By:
Journal of Clinical Epidemiology|December 31, 2025
A protocol for the development of a Core Outcome Set (COS) for adults with depressionC Veal, K R Krause, E I Fried, et al.
Blood Advances|March 17, 2026
Perioperative Management of Antithrombotic Therapy in Patients with Thrombotic Antiphospholipid SyndromeMiguel L Paquette, Sebastien Miranda, Yan Xu, et al.
Transfusion|March 6, 2019
Effects of blood storage age on immune, coagulation, and nitric oxide parameters in transfused patients undergoing cardiac surgeryPhilip C Spinella, Roman M Sniecinski, Felicia Trachtenberg, et al.
The Journal of Infectious Diseases|May 4, 2004
Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohortJeffrey J Post, Yong Pan, Anthony J Freeman, et al.
Anesthesia and Analgesia|July 25, 2022
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Antithrombin Supplementation in Patients at Risk for Antithrombin Deficiency After Cardiac SurgeryMichael George Moront, Michael K Woodward, Michael K Essandoh, et al.
Lancet (London, England)|September 12, 1998
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study GroupE Abraham, A Anzueto, G Gutierrez, et al.
Nature Communications|September 5, 2023
Antarctic evidence for an abrupt northward shift of the Southern Hemisphere westerlies at 32 ka BPAbhijith U Venugopal, Nancy A N Bertler, Jeffrey P Severinghaus, et al.
Thrombosis and Haemostasis|May 29, 2015
Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatranCharles V Pollack, Paul A Reilly, Richard Bernstein, et al.
Anesthesiology|February 1, 2005
A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypassMichael S Avidan, Jerrold H Levy, Jens Scholz, et al.
Science Advances|April 25, 2025
Obliquity disruption and Antarctic ice sheet dynamics over a 2.4-Myr astronomical grand cycleNicholas B Sullivan, Stephen R Meyers, Richard H Levy, et al.
Pageof 93

Showing results (871-880 of 925) with videos related to

Sort By:
Pageof 93
Journal of Clinical Epidemiology|December 31, 2025
A protocol for the development of a Core Outcome Set (COS) for adults with depressionC Veal, K R Krause, E I Fried, et al.
Blood Advances|March 17, 2026
Perioperative Management of Antithrombotic Therapy in Patients with Thrombotic Antiphospholipid SyndromeMiguel L Paquette, Sebastien Miranda, Yan Xu, et al.
Transfusion|March 6, 2019
Effects of blood storage age on immune, coagulation, and nitric oxide parameters in transfused patients undergoing cardiac surgeryPhilip C Spinella, Roman M Sniecinski, Felicia Trachtenberg, et al.
The Journal of Infectious Diseases|May 4, 2004
Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohortJeffrey J Post, Yong Pan, Anthony J Freeman, et al.
Anesthesia and Analgesia|July 25, 2022
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Preoperative Antithrombin Supplementation in Patients at Risk for Antithrombin Deficiency After Cardiac SurgeryMichael George Moront, Michael K Woodward, Michael K Essandoh, et al.
Lancet (London, England)|September 12, 1998
Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study GroupE Abraham, A Anzueto, G Gutierrez, et al.
Nature Communications|September 5, 2023
Antarctic evidence for an abrupt northward shift of the Southern Hemisphere westerlies at 32 ka BPAbhijith U Venugopal, Nancy A N Bertler, Jeffrey P Severinghaus, et al.
Thrombosis and Haemostasis|May 29, 2015
Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatranCharles V Pollack, Paul A Reilly, Richard Bernstein, et al.
Anesthesiology|February 1, 2005
A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypassMichael S Avidan, Jerrold H Levy, Jens Scholz, et al.
Science Advances|April 25, 2025
Obliquity disruption and Antarctic ice sheet dynamics over a 2.4-Myr astronomical grand cycleNicholas B Sullivan, Stephen R Meyers, Richard H Levy, et al.
Pageof 93